Paul-Ehrlich-Institut

Phar­ma­covig­i­lance (hu­man)

The WHO defines pharmacovigilance as the activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem.

Current safety information* (German only)

* does not include reports from haemovigilance, IVD vigilance, ATMP vigilance, or veterinary pharmacovigilance